Eli Lilly has temporarily paused shipments of its weight-loss drug Mounjaro in the UK, ahead of a new price hike for the ...

The latest results from a trial of a pill form popular GLP-1 medications offer enough information for the Eli Lilly to ...

A Fierce Battle for Weight-Loss Supremacy The weight-loss drug market has become a battleground, ignited by the runaway ...

Eli Lilly announced this week that its new weight-loss pill, orforglipron, cleared its latest Phase 3 trial, bringing it closer to potential Food and Drug Administration (FDA) approval. Compared with ...

Eli Lilly's orforglipron outshines Novo Nordisk's oral semaglutide with efficacy & scalability, promising growth in the ...

In a study of more than 1,600 adults with type 2 diabetes, those who received the highest dose of orforglipron on average shed 10.5% of their weight.

Eli Lilly partners with JD Health to expand in China’s obesity drug market, leveraging digital platforms for growth.

Eli Lilly shares gained Tuesday as results from a new study moved the drugmaker closer to applying for approval of its ...

Eli Lilly and Company (NYSE:LLY)’s shares have become one of the most valuable in the sector due to its strong presence in the weight loss drug industry.

Eli Lilly says its weight loss pill orforglipron could win approval this year after a trial showed over 10% weight loss in ...

New data from Eli Lilly says its daily, oral GLP-1 pill may help people who have obesity and people who have Type 2 diabetes ...

The drug's US manufacturer has asked UK distributors to stop taking orders from pharmacies until next month's price increase.